Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04372394 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects
A Phase 1 study, sponsored by Hutchison Medipharma Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT04372394 is a Phase 1 study that has completed, run by Hutchison Medipharma Limited. The registered enrollment target is 28 participants.
The verdict
NCT04372394, a Phase 1 study, has completed, sponsored by Hutchison Medipharma Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will be a 2-period study conducted with 26 healthy male or female subjects. Subjects will be randomly assigned to either receive a single dose of surufatinib with food in period 1, then without food in period 2, or vice-versa.
Interventions
- DRUG surufatinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2021-03-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04372394
The ClinicalTrials.gov registry entry for NCT04372394 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hutchison Medipharma Limited, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which surufatinib is the first listed.
NCT04372394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04372394 about?
NCT04372394 is a clinical study titled "A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects". This study will be a 2-period study conducted with 26 healthy male or female subjects. Subjects will be randomly assigned to either receive a single dose of surufatinib with food in period 1, then without food in period 2, or vice-versa.
What is the current status of trial NCT04372394?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2020-08-14. Estimated completion is 2021-03-02.
What interventions are being tested in trial NCT04372394?
The interventions under investigation include: surufatinib (DRUG).
Who is sponsoring clinical trial NCT04372394?
This trial is sponsored by Hutchison Medipharma Limited, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.